Viewing Study NCT03083704


Ignite Creation Date: 2025-12-24 @ 9:07 PM
Ignite Modification Date: 2025-12-25 @ 6:58 PM
Study NCT ID: NCT03083704
Status: COMPLETED
Last Update Posted: 2023-08-08
First Post: 2017-03-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Healthy Volunteer PK/PD, Safety and Tolerability Study of Second Generation Andexanet Alfa
Sponsor: Portola Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module